Handelsavisen
prelaunch
Companies Industrials BIOEX.ST
BI
BIOEX.ST Nasdaq Stockholm Environmental Services & Equipment

Bioextrax AB publ

kr2,41
Open in Charts → Attach watcher ⌖
SEK
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
0,00 %
Op margin
-2 356,5 %
ROE
-83,5 %
Net margin
-2 338,8 %
Debt / equity
0,00
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

Bioextrax AB publ provides industrial services focused on environmental solutions, including waste management and recycling technologies.

Business. Bioextrax AB publ (BIOEX.ST) is an industrial services company operating within the Environmental Services & Equipment industry. The firm is headquartered in Sweden and is primarily listed on the Nasdaq Stockholm exchange. Specific details regarding its operating segments and geographic revenue mix are not available.

Classification92 %
SectorIndustrials
Business sectorIndustrial & Commercial Services
IndustryEnvironmental Services & Equipment
ActivityIndustrial Services
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
not yet wired
Profitability
-83,5 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning BIOEX.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials · THIS SECTOR−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to BIOEX.ST. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Bioextrax AB publ (BIOEX.ST) is an industrial services company operating within the Environmental Services & Equipment industry. The firm is headquartered in Sweden and is primarily listed on the Nasdaq Stockholm exchange. Specific details regarding its operating segments and geographic revenue mix are not available.

    Classification92 %
    SectorIndustrials
    Business sectorIndustrial & Commercial Services
    IndustryEnvironmental Services & Equipment
    ActivityIndustrial Services
    AI synthesis
    GENERATED

    Bioextrax operates with a debt-free capital structure, as evidenced by a debt-to-equity ratio of 0.0. The company holds SEK 3.93 million in cash and equivalents, but its operating cash flow is negative at SEK -26.05 million, indicating a reliance on external financing or asset sales to fund operations. The current ratio of 1.58 suggests the company can cover its short-term liabilities with its current assets, but the negative free cash flow of SEK -16.73 million raises concerns about long-term liquidity.

    Profitability metrics are severely negative, with a return on equity of -83.46% and a return on assets of -71.6%. These figures are well below the typical thresholds for sustainability in the Environmental Services & Equipment industry, where returns on equity and assets are generally expected to be positive and in the low single digits. The company reported a net loss of SEK -17.71 million, with operating income also negative at SEK -17.84 million.

    The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification in the latest financials. This lack of diversification increases exposure to regional economic downturns or regulatory changes that could impact the company's primary market.

    The company's growth trajectory is uncertain, with no disclosed revenue growth in the latest period and no forward-looking guidance provided in the available data. The negative operating and net income figures suggest the company is not currently generating value for shareholders and may require significant restructuring or capital injections to achieve profitability.

    Risk factors include the company's negative cash flow and lack of long-term debt, which may limit its ability to fund expansion or R&D initiatives. The risk assessment indicates low dilution potential, but the liquidity risk is rated as low, suggesting the company has sufficient cash reserves to meet short-term obligations. No immediate filing-based liquidity or dilution flags were detected, but the negative operating cash flow and free cash flow raise concerns about long-term sustainability.

    Recent events include the latest financial filing, which shows continued losses and negative cash flows. No recent earnings call transcripts or press releases were available to provide additional context on the company's strategic direction or operational performance.

    Key takeaways
    • Bioextrax is operating at a significant loss, with a return on equity of -83.46% and a return on assets of -71.6%.
    • The company has no long-term debt but is generating negative cash flows, raising concerns about long-term liquidity.
    • Revenue is concentrated in a single segment, with no geographic diversification disclosed.
    • No immediate dilution or liquidity flags were detected, but the company's financial performance suggests a need for strategic intervention.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Valuation

    Market price
    kr2,41
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    kr21.2M
    Net cash
    kr3.9M
    Current ratio
    1.6
    Debt / equity
    0.0
    ROA
    -71.6%
    ROE
    -83.5%
    Cash conversion
    147.0%
    CapEx / revenue
    -20.1%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskLow
    Filing-based flags
    • No immediate filing-based liquidity or dilution flags were detected.

    Benchmarks vs cohort

    Op Margin-2 356,5 %Bottom quartile
    Net Margin-2 338,8 %Bottom quartile
    ROE-83,5 %Bottom quartile
    Capex / Rev-20,1 %Below median
    D/E0,00Above P75
    Cash Conv1,47Above median

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    Source documents
    • Bioextrax AB publ Market data — financials · 2026-05-27

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    BIOEX.STCanonical
    Nasdaq Stockholm · SEK

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskLow
    No immediate filing-based liquidity or dilution flags were detected.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    — missing data
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage